Introduction
Bone marrow-derived cells enriched for cells expressing hematopoietic stem cell (HSC) markers were recently reported to express early neural genes and give rise to cells with a neuronal phenotype both in vitro cultures after stimulation with neurotropic factors and in vivo after delivery to the damaged areas of the central nervous system (CNS). Furthermore, several recent reports suggest that bone marrow (BM)-derived hematopoietic stem cells, [1] [2] [3] mesenchymal stem cells (MSCs), [4] [5] [6] and mononuclear cells (MNCs). 7 exhibit a high degree of differentiation plasticity and thus could potentially be employed to regenerate damaged brain or spinal cord. These reports, however, have been challenged vigorously and the concept of transdifferentiation of adult stem cells has recently been called into question [8] [9] [10] Furthermore, the identity of the specific BMderived cellular subset(s) capable of regenerating the CNS remains elusive. These uncertainties are part of an ongoing intense debate regarding the mechanism responsible for the functional benefits observed following cellular transplantation. Three basic possibilities have been proposed: cell fusion, 11 transdifferentiation, 12 and paracrine/proangiopoietic effects of transplanted cells. 8 First, it has been suggested that HSCs may fuse with somatic cells and such fusion-derived cells may acquire markers of both 'parental' cells, giving the false impression that transplanted HSCs switch their differentiation path . 11 On the other hand, it is proven that under certain circumstances, cells may undergo epigenetic changes caused by external stimuli that modulate the expression of lineage-specific genes. 13 This concept is further supported by the observation that nuclei isolated from differentiated somatic cells are 'plastic' and may be reprogrammed and dedifferentiated when injected into the cytoplasm of enucleated oocytes, as seen during reproductive/therapeutic cloning.
14 A similar effect may occur in stem cells isolated from their physiological environment and exposed to an organspecific milieu, leading to transdifferentiation. 15 Furthermore, several proangiopoietic factors secreted by HSCs, MSCs and MNCs may also contribute to final regeneration.
In this report, we propose a fourth possibility that may reconcile the apparently discordant results obtained by the proponents of cell fusion and transdifferentiation. We have recently demonstrated that human and murine BM in addition to HSCs and endothelial progenitors 16, 17 contains nonhematopoietic CXCR4 þ tissue-committed stem cells (TCSCs) expressing mRNA for various tissues, including skeletal muscle, heart, liver, and neural tissue. 18, 19 Based on this we have proposed that these CXCR4 þ nonhematopoietic TCSCs contributed to the organ/tissue chimerism observed after transplantation of BM-or mobilized peripheral blood (mPB)-derived cells in earlier reports. In support of this notion on-fusion-related contribution of transplanted BM-and mPB-derived cells to chimerism of CNS, this was recently demonstrated in patients after hematopoietic transplants. 20 The fact that TCSCs reside in the BM 19 and are released into the PB during pharmacological mobilization 18 or tissue injury suggests that they may potentially play a role in organ regeneration.
Based on these findings, we postulated that the adult BM also harbors TCSCs committed to the neural lineage 18, 19, 21 and the present study was performed to better characterize these cells. We provide evidence that postnatal murine BM harbors a population of CXCR4 þ /lin À /CD45 À nonhematopoietic MNCs that express early neural markers and that these cells are able to form in vitro neuro-like spheres. These cells expressing markers of neural TCSCs are mobilized into the PB following stroke and are capable of migrating towards SDF-1, HGF, and LIF gradients. We hypothesize that these cells may potentially be purified from BM or mPB, expanded in vitro and used for therapeutic neural regeneration.
Materials and methods
The present study was performed in accordance with the guidelines of the Animal Care and Use Committee of the University of Louisville School of Medicine and with the Guide for the Care and Use of Laboratory Animals (Department of Health and Human Services, Publication No.
[NIH] 86-23).
Bone marrow cells
MNCs were isolated from murine BM flushed from the femurs of pathogen-free, 2-, 3-week-and 1-, 2-, 6-and 12-month-old female C57Bl/6 mice and 3-6-week old C57BL/6-Tg(ACTB-EGFP)1Osb/J mice (Jackson Laboratory, Bar Harbor, ME, USA) and subjected to Ficoll-Paque centrifugation to obtain lightdensity MNCs. Sca-1 þ cells were isolated by employing paramagnetic mini-beads (Miltenyi Biotec, Auburn, CA, USA) according to the manufacturer's protocol.
FACS isolation
þ cells were isolated from a suspension of murine BMMNCs by multiparameter, live sterile cell sorting (FACSVantage SE; Becton Dickinson, Mountainview, CA, USA). Briefly, BMMNCs (100 Â 10 6 cells/ ml) were resuspended in cell sort medium (CSM), containing 1 Â Hank's Balanced Salt Solution without phenol red (GIBCO, Grand Island, NY, USA), 2% heat-inactivated fetal calf serum (FCS; GIBCO), 10 mM HEPES buffer (GIBCO), and 30 U/ml of Gentamicin (GIBCO). The following directly conjugated mAbs were employed to stain these cells: anti-stem cell antigen (Sca-1)-PE (clone D7), anti-CD45-APC (clone 30-F11), anti-CD45R/B220-FITC (clone RA3-6B2), anti-Gr-1-FITC (clone RB6-8C5), anti-TCRab FITC (clone H57-597), and anti-TCRgz FITC (clone GL3). All mAbs were added at saturating concentrations and the cells were incubated for 30 min on ice and washed twice, then resuspended for sort in CSM at a concentration of 5 Â 10 6 cells/ml.
Hematopoietic assays
For cell proliferation assays, sorted murine BMMNCs were plated in serum-free methylcellulose cultures in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF) þ interleukin (IL)-3 for colony-forming unit-granulocyte macrophage (CFU-GM) colonies, erythropoietin (EPO) þ stem cell factor (SCF) for burst forming unit-erythroid (BFU-E) colonies and thrombopoietin (TPO) for CFU-megakaryocytic colonies as described. 22, 23 Using an inverted microscope, murine hematopoietic colonies were scored on day 7. For the CFU-S assays, female C57Bl/6 mice (4-6 weeks old) were irradiated with a lethal dose of g-irradiation (900 cGy). After 24 h, the mice were transplanted with 1 Â 10 4 sorted BMMNCs obtained from syngeneic mice via tail-vein injection. On day 12, spleens were removed and fixed in Tellysyniczky's fixative and CFU-Spleen colonies were counted on the surface of the spleen using a magnifying glass as previously described. 22 
Chemotactic isolation
After the isolation of murine BMMNCs, cells were resuspended in serum-free medium and equilibrated for 10 min at 371C. The lower chambers of Costar Transwell 24-well plates, 6.5-mm diameter, 5-mM pore filter (Costar Corning, Cambridge, MA, USA) were filled with 650 ml of serum-free medium and 0.5% BSA containing SDF-1 (200 ng/ml), HGF (10 ng/ml), or LIF (100 ng/ml) or with medium alone (control). 18, 19 In specific experiments, we employed supernatants from tissue homogenates of the ischemic hemisphere or control, the intact hemisphere of the brain. Cell suspensions (100 ml) were added to the upper chambers. The plates were incubated at 371C, 95% humidity, 5% CO 2 for 3 h and evaluated under an inverted microscope. Cells from the lower chambers were collected and their numbers counted by FACS analysis (FACScan, Becton Dickinson). 23 The results are presented as a chemotactic index (the ratio of the number of cells migrating toward the medium with SDF-1, HGF or LIF to the number of cells migrating toward the medium alone). BM cells from young 3-week-old mice were employed in directional migration experiments to supernatants harvested from tissue homogenates of the ischemic hemisphere. Some of these experiments were performed on BM cells preincubated for 30 min at 371C in the presence of 1 mM T140-truncated polyphemusin analogue (a gift from Dr Nobutaka Fuji, Kyoto University, Japan) or preincubated in the presence of 1 mM c-Met inhibitor, K-252a (Calbiochem-Novabiochem Int., USA) or with anti-gp130 antibody (R&D System, Minneapolis, USA).
Real-time RT-PCR
For analysis of GFAP, Nestin, b-III-tubulin, Olig1, Olig2, Oct-4, VE-cadherin, Myf-5, and MyoD mRNA levels, total mRNA was isolated from cells with the RNeasy Mini Kit (Quiagen, Inc.). mRNA was reverse-transcribed with TaqMan Reverse Transcription Reagents (Applied Biosystems, Foster City, CA, USA). Quantitative assessment of GFAP, Nestin, b-III-tubulin, Olig1, Olig2, Oct-4, VE-cadherin, Myf-5 and MyoD, and b-actin mRNA levels was performed by real-time RT-PCR using an ABI PRISM s 7000 Sequence Detection System (ABI, Foster City, CA, USA). All of the primer sequences are provided in the Supplementary Table 1 below. Primers were designed with Primer Express software. A 25 ml reaction mixture containing 12.5 ml SYBR Green PCR Master Mix and 10 ng of cDNA template, forward and reverse primers were used. The threshold cycle (C t ), that is, the cycle number at which the amount of amplified gene of interest reached a fixed threshold, was subsequently determined. Relative quantitation of GFAP, Nestin, b-III-tubulin, Olig1, Olig2, Oct-4, VE-cadherin, Myf-5, and MyoD mRNA expression was performed with the comparative C t method. The relative quantization value of target, normalized to an endogenous control b-actin (house-keeping) gene and relative to a calibrator, is expressed as 2
ÀDDCt (-fold difference), where DC t ¼ (C t of target genes (GFAP, Nestin, b-IIItubulin, Olig1, Olig2, Oct-4, VE-cadherin, Myf-5 and MyoD)) -(C t of endogenous control gene (b-actin), and DDC t ¼ (DC t of samples for target gene) -(DC t of calibrator for the target gene).
To avoid the possibility of amplifying contaminating DNA (i) all of the primers for real-time RT-PCR were designed with an intron sequence inside cDNA to be amplified; (ii) reactions were performed with appropriate negative controls (templatefree controls); (iii) a uniform amplification of the products was rechecked by analyzing the melting curves of the amplified products (dissociation graphs); (iv) the melting temperature (T m ) was 57-601C, the probe T m was at least 101C higher than primer T m ; and (v) gel electrophoresis was performed to confirm the correct size of the amplification and the absence of nonspecific bands.
Neurosphere formation
þ BMMNCs isolated from C57BL/6-Tg(ACTB-EGFP)1Osb/J were coplated (8 Â 10 4 cell/well) with unpurified BM cells (1 Â 10 6 cells/well) that provided a conducive milieu for cell survival in Complete NeuroCultTM Proliferation Medium (StemCell Technologies, Inc., Vancouver, BC, Canada) with rhEGF (StemCell Technologies, Inc., Vancouver, BC, Canada). Cells were maintained in this medium and the growth factor was replaced each day. After 7-10 days, spheroids (clusters of floating cells) became visible. To explore their potential for self-renewal, primary spheres were dispersed into single cells. Primary spheres were picked from 7-day cultures, incubated with trypsin-EDTA, and then mechanically dispersed with a polished Pasteur pipette. Trypsin was inhibited by adding the same volume of 10% FBS, cells were spun down immediately, resuspended in sphere culture medium in identical growth factor conditions as the primary culture, and plated in uncoated 96-well plates. Passage ability was assessed by identifying new neurospheres after a further 6-7 days of culture.
Neurosphere differentiation
Neurospheres were collected, centrifuged, and passaged after trituration. Subsequently, they were plated on poly-L-ornithin (15 mg/ml)-coated glass bottom wells (Willco Wells BV, Amsterdam, The Netherlands). Cells were plated in Neurocult Basal Medium with Differentiation Supplement (StemCell Technologies, Inc., Vancouver, BC, Canada) and bFGF-2 at 20 ng/ml (Chemicon Int., Temecula, CA, USA) and were cultivated for 10 days. Cells were processed for immunohistochemical studies.
Model of ischemia brain damage
In this model, an intravenously injected photosensitizer, which is the fluorescein derivative Rose Bengal, is optically excited and singlet oxygen is generated. 24, 25 Wild-type mice (n ¼ 24/ group) (B6,129 strain, body wt. 25-35 g, age 12-16 weeks) were treated with an intravenous injection of Rose Bengal (20 mg/kg; 10 mg/ml concentration in saline infusion: 0.2 ml/animal) and irradiated by 550 nm green light from a mercury lamp source through an intact cranium. Mice (n ¼ 6 mice in each group at each time point) were killed at 24 h, 48 h, 1 week, or 3 weeks after the onset of stroke. Following euthanasia, blood samples (1.0-1.5 ml from each mouse) were collected in heparin-rinsed syringes for the isolation of PBMNCs. Brain tissue samples were harvested from the ischemic and nonischemic regions and frozen immediately in liquid nitrogen for mRNA extraction.
Fluorescent analysis
The expression of each antigen was examined in separate experiments at least three times. After differentiation, the cells were fixed in 3.5% paraformaldehyde for 20 min, permeabilized by 0.1% Triton X100, washed in PBS and stained with antibodies to NeuN (1:100, mouse monoclonal IgG; Chemicon Int., Temecula, CA, USA), O4 (1:300, mouse monoclonal IgM; Chemicon Int., Temecula, CA, USA), glial fibrillary acidic protein ( Neural
Immunohistochemical analysis
The brain sections were permeabilized and blocked with 10% goat serum in PBS for 30 min at room temperature. Primary goat polyclonal SDF-1 (c-19) antibody (1:100 Santa Cruz Biotechnology., Santa Cruz, CA, USA) was applied overnight at room temperature, the sections were then incubated with secondary Texas Red-conjugated donkey antigoat (1:100 Jackson Lab., West Grove, PA, USA) in a dark humidified tray on a shaker for 2 h at room temperature. Slides were washed, mounted, and examined using a Zeiss Axioskop fluorescence microscope.
Statistical analysis
Data are reported as mean7s.d. All statistical analyses were performed on a Macintosh computer (PowerBase 180) using the Instat 1.14 software (GraphPad, San Diego, CA, USA). Data were analyzed using the nonparametric Mann-Whitney test. Statistical significance was defined as Po0.01.
Results

Markers for neural TCSC in chemoattracted BM-derived cells
RT-PCR analysis was performed on BM cells derived from mice at five different ages that were attracted to SDF-1, HGF/SF, or LIF gradients. Figure 1 demonstrates that these chemoattracted cells, depending on cell donor age, express a significantly higher level of mRNA for GFAP and nestin. mRNA for neural markers, GFAP and nestin, was easily detectable in cells chemoattracted to SDF-1 and LIF gradients from 1-month-old mice, which corresponds with the time of their rapid growth in body mass. Subsequently, this responsiveness to SDF-1 in contrast to their responsiveness to LIF was markedly diminished after 2 months (Figure 1 ). We also noticed that, with increasing age, cells expressing mRNA for GFAP and nestin were increasingly attracted to HGF gradients with a peak in 6-month-old mice ( Figure 1 , middle panel). Cells expressing mRNA for GFAP and nestin were not appreciably attracted to SDF-1, HGF/SF, or LIF gradients in middle-aged 1-year-old mice mice which corresponds to a 50-year-old human (Figure 1) . Finally, to exclude the possibility that SDF-1, HGF, or LIF could induce changes in expression of genes encoding early muscle, neural and liver markers, we employed in our experiments BMMNCs and BM Sca-1 þ cells that had been stimulated for 5 h with a chemotactic dose of these factors. No changes in expression of GFAP or nestin were observed (data not shown).
FACS isolation of neural TCSCs
Since murine cells expressing the early hematopoietic stem cell marker, Sca-1, have been reported to contribute to tissue regeneration, [26] [27] [28] we sought to determine whether these cells contain neural TCSCs. To address this question, we employed real-time RT-PCR to compare the expression of mRNA for neural markers between different subsets of cells isolated from murine BM based on CD45 expression. Sorted murine Sca-
À cells (Figure 2a ) were highly enriched (up to 1400 Â ) in mRNA for early neural markers (Figure 2b) . Furthermore, by employing direct immunohistochemical staining (Figure 2c and  d (Figure 3a) . The cells present in neurospheres were able to grow secondary neurospheres and the neural commitment of these neurospheres was confirmed by detection of nestin expression on their surface (Figure 3b ) and the ability of neurosphere-derived cells to differentiate into b III tubulin and nestin-positive neuron-like-, O4 and MBP-positive oligodendrocyte-like-and GFAP-positive glia-like cells (Figure 3 panel c) .
Together, these data demonstrate for the first time that BMMNCs expressing neural markers are abundant within a population of nonhematopoietic CXCR4
Release of neural TCSCs to the PB following stroke
Real-time RT-PCR was employed to detect the expression of mRNA for neural and endothelial markers in PBMNCs collected at specific time points after stroke. There was a marked increase in mRNA content for GFAP, nestin but not Myf5 (marker of skeletal TCSCs) in PBMNCs harvested after stroke, which peaked at 24 h poststroke and was maintained at an increased level for 3 weeks (Figure 4) . Interestingly, these cells also highly expressed mRNA for Oct-4, which suggests that some of the mobilized cells due to the stroke express also this marker of pluripotent stem cells. Importantly, at 24 h, the expression of GFAP and nestin was detected in B3.5 and B2.4% of the PBMNCs by immunocytochemistry, respectively (Figure 4b ). 
À MNCs to form neurospheres. Owing to the inability of the highly purified cells to differentiate when cultured alone,
þ BMMNCs were cocultured with unpurified GFP-negative BMMNCs in neural proliferating chemically defined medium. After 7-9 days, GFP These cells were not detectable in control sham-operated animals. Together, these data indicate that neural TCSCs are released from the BM into the PB in response to stroke in a manner analogous to what has been described for cardiac and endothelial progenitors.
30,31
Expression of SDF-1, HGF, and LIF following stroke
We evaluated the expression of mRNA for SDF-1, HGF, and LIF in the brain hemisphere affected by stroke of mice at 24 h, 48 h, 1 week, and 3 weeks after inducing stroke. The mRNA for SDF-1 was upregulated (B4 times) at 24 h after stroke as compared to the contralateral unaffected brain hemisphere, increasing subsequently B12 times at 1 week (Figure 5a ) and up to B250 at 3 weeks after stroke, respectively (not shown). More importantly, the upregulation of SDF-1 mRNA was confirmed at the protein level by employing immunohistochemical analysis of the sagittal section of the stroke area (Figure 5b ). Real time RT-PCR also revealed an upregulation of mRNA for LIF (B20 times) and HGF (B7 times) at 1 week after stroke (Figure 5a ).
Neural TCSCs are chemoattracted to supernatants from brain tissue affected by stroke in an SDF-1-, HGF-, and LIF-dependent manner
Having found that the supernatant from brain tissue damaged by stroke is enriched with mRNA for chemoattractants for TCSCs ( Figure 5 ), we examined whether this supernatant would indeed attract neural TCSCs. BMMNCs from 3-week-old mice were allowed to migrate to supernatants from brain tissue obtained from control (intact hemisphere) and stroke-affected (ischemic hemisphere) brain tissue harvested at 1 week and 3 weeks after stroke onset.
We noticed that BMMNCs were chemoattracted to supernatants from damaged brain tissue harvested at 1 week (Figure 6a ) and 3 weeks (Figure 6b ) after stroke. This chemotactic response to CM derived from brain tissue affected by stroke derived at week 1 and week 3 after induction of stroke could be inhibited by pretreatment of BMMNCs with T140, K-252a compounds, or anti-gp130 Ab, which are known inhibitors of CXCR4, c-Met, and LIF receptors, respectively ( Figure 6 ). Interestingly, when combined together, these inhibitors completely blocked the chemotaxis of BMMNCs to the supernatant of the ischemic cortex (Figure 6a, b) .
Most importantly, a striking upregulation of mRNA for GFAP, nestin, and VE-cadherin was detected in BMMNCs attracted to supernatants from brain tissue damaged by stroke (Figure 6c ). These data together suggest the identity of these cells as neural (GFAP þ /nestin þ ) and endothelial (VE-cadherin þ ) TCSCs. At the same time, these cells did not express markers for skeletal muscle (MyoD and Myf-5) TCSCs (Figure 6 panel c) suggesting a selectivity in the chemoattraction of TCSCs.
Neural TCSCs are enriched in BM of young mice
Finally, since we noticed that the expression for markers of early pluripotent/tissue committed stem cells is higher in BMMNCs from younger mice, 32, 33 we compared by real-time RT-PCR expression of markers for neural TCSCs in BMMNCs harvested from 3-week-old and 1-year-old C57Bl6 animals. As expected, we noticed a decrease in expression of mRNA for GFAP, nestin, and b-III-tubulin in BMMNCs from older mice by B14, 22, and 18 times, respectively. At the same time, FACS analysis revealed that the number of Sca-1 þ lin À CD45 À cells in BM from 1-year- Neural tissue-committed cells in the bone marrow M Kucia et al old animals is reduced B7-10 times as compared to 3-week-old animals (not shown).
DISCUSSION
Evidence from numerous experimental and clinical studies supports the notion that BM-derived cells are capable of inducing regeneration in various tissues/organs 34 including the CNS. 12, 35, 36 Similarly, the BM has been demonstrated to be a source of microglia progenitors for brain tissue. These BMderived microglia precursors egress from marrow and subsequently via circulating blood home into the brain. 37 A recent report demonstrated that adult human BM-derived cells could contribute to long-term neuropoiesis without cell fusion. 12, 38 As reported in three sex-mismatched female BM recipients, FISH analysis for the Y chromosome proved that B1% of hipocampal neurons were of male origin and in addition to the single Y chromosome these cells also contained a single X chromosome -which precludes the phenomenon of cell fusion. 12 These observations support that cells important for maintaining CNS function may be BM-derived.
It is widely accepted that BM harbors a plethora of precursor and mature cell types, including several distinct types of hematopoietic stem/progenitor cells, endothelial progenitors, and perhaps hemangioblasts 32, [39] [40] [41] Despite the demonstration of donor-derived neural cells after hematopoietic transplant or neural repair with BM-derived cells, the ability of committed adult 'hematopoietic' stem cells to transdifferentiate into cells of nonhematopoietic lineages remains highly controversial. Resolution of this issue is of paramount importance not only from a conceptual standpoint but also because large-scale regenerative therapies would necessitate the precise identification and in vitro expansion of the specific BM cellular subset responsible for neural regeneration. Moreover, the discrepancies in regenerative outcome in currently published reports may be explained by whether TCSCs were excluded by the sorting approach to obtain stem cells.
The BM has been shown to contain a mobile pool of endothelial TCSCs that may play an important role in organ regeneration. 41, 42 In agreement with this notion, we have recently demonstrated that the adult BM contains a population of highly mobile SDF-1-responsive CXCR4 þ cells that express mRNA for TCSCs and even more primitive pluripotent stem cells 18, 32, 33, 43 In the present study, we investigated in more detail BM-derived TCSCs expressing markers for neural differentiation. We found that TCSCs expressing neural TCSC markers reside within a population of murine CXCR4
À BMMNCs. The ability of these cells to migrate to SDF-1, HGF, and LIF gradients indicates that these cells express CXCR4, c-Met, and LIF receptors. Together, these results indicate that neural TCSCs reside in postnatal BM and constitute a subset of cells that express a conventional marker of murine HSC, Sca-1. This observation which may explain at least in part the presence of donor-derived neural cells in the brain and the functional improvement after stroke observed following transplantation of BM-or mobilized PB-derived HSCs 1,44 as well as expression of neural genes found to be expressed in BM-derived cells enriched for HSCs. 45 Furthermore, since Sca-1 is also expressed in BM-derived endothelial progenitors, our observations may explain the increased vascularization of damaged brain after injection of these cells. 1 TCSCs identified by us are enriched within CXCR4
þ /Sca-1 þ /CD45 À cells and are different from HSCs as evidenced by the fact that they neither grow hematopoietic colonies in vitro nor form CFU-S colonies in lethally irradiated littermates in vivo. In the aggregate, these data demonstrate for the first time the existence of cells expressing markers or neural TCSCs in postnatal BM and identify them as a subpopulation of cells distinct from HSCs. However, the final proof that these cells may produce functional neurons and contribute in vivo to regeneration of damaged brain requires further studies.
One of the factors that may affect the outcome of studies of BM-derived cells for neural regeneration is the age of the BM. We observed an age-dependent change in the abundance of neural TCSCs in murine BM, resulting in much lower detectable levels in 1-year-old middle aged mice. These striking differences between old and young animals suggest that TCSCs are deposited in BM early in ontogenesis during rapid body growth/expansion. 30, 39 We also found that the responsiveness of these cells to SDF-1, HGF, and LIF gradients varies with age. While the cells from younger mice responded robustly to SDF-1 and LIF gradients, the cells from older animals were chemoattracted by HGF. These observations suggest a possible age-dependent phenotypic (density and/or functionality) shift involving the expression patterns of receptors (CXCR4, c-Met, and LIF-R) in neural TCSCs. Regardless of this, the striking difference in chemotactic response of neural TCSCs to these factors has obvious practical implications for BM cell-based therapies. However, we cannot exclude the involvement of Neural tissue-committed cells in the bone marrow M Kucia et al other motomorphogens, for example, VEGF or FGF-2 in this process. 46, 47 It has been shown that endothelial TCSCs can be released from BM/tissue niches, circulate and are finally chemoattracted to ischemic tissue in an SDF-1-CXCR4-dependent manner. 48 Similarly, we demonstrated recently that in addition to endothelial precursors, cardiac TCSCs are also mobilized in both humans and mice into the PB following heart infarct, with a peak around 24 and 48 h, respectively, after MI and a gradual decline to nearly undetectable levels by 96 h (mice) 30 and by 7 days (human). 31 In this report, neural TCSCs were also detectable in among PB MNCs following stroke. However, their presence was elevated for a prolonged period of time being detectable up to 3 weeks after stroke. We noticed by direct immunohistochemical staining, 24 h after stroke the presence in PB of cells that may express GFAP and nestin. Since these cells were not detectable in control animals, our data suggest that egress of these cells into the PB is triggered by the stroke. In Figure 6 BM-derived neural TCSCs are chemoattarcted by the damaged cortex in a SDF-1-, HGF-, and LIF-dependent manner. BMMNCs from 3-week-old mice are chemoattracted to supernatants from ischemic cortex tissue. BMMNCs were added to the upper transwell chambers and allowed to migrate to the conditioned media (CM, supernatants) from control (intact hemisphere) and the ischemic hemisphere of brain tissue. The number of cells that migrated to supernatants from the ischemic cortex tissue is shown as a chemotactic index. (a, b) Chemotaxis of BMMNCs to the conditioned media from control and ischemic brain tissue 1 week (a) and 3 weeks (b) after stroke in the absence or presence of inhibitors to CXCR4 (T140), c-Met (K252a), and LIF-R (anti-gp130 Ab). DMSO was added as a control (solvent for K252a). (c) Expression of mRNA for neural (GFAP and Nestin), endothelial (VE-cadherin), and skeletal muscle (Myf5 and MyoD) TCSCs in control (unpurified) BMMNCs and BMMNCs that migrated to supernatants from the ischemic hemisphere 1 week after stroke. In all of these experiments, the BM of five mice was pooled and the chemotactic assays were performed in triplicate. Data are mean7s.d. *Po0.0001 vs control.
addition, our data demonstrate that the expression of SDF-1 increased in damaged brain during the first 24 h and subsequently was further upregulated together with HGF, and LIF during the first week after stroke. Interestingly, this increase in SDF-1 expression 24 h after stroke corresponded with an appearance of circulating MNC that express markers of neural and endothelial TCSCs. Furthermore, BMMNCs enriched in neural markers were chemoattracted to supernatants from the ischemic hemisphere and this chemotaxis could be significantly abolished by T140, K252a, and anti-gp130, specific inhibitors of CXCR4, c-Met, and LIF-R, respectively. These results imply that these receptors play a pivotal role in orchestrating the moblilization/migration of neural TCSCs.
In the aggregate, we provide evidence that BM contains a mobile pool of neural TCSCs that respond to SDF-1, HGF, and LIF gradients. In support of this, it has been reported that knockout mice of SDF-1 or CXCR4 display a defect in the development of the central nervous system. 49, 50 This corroborates with our findings, showing that SDF-1, which plays a pivotal role in the developmental migration of neural stem cells, was one of the crucial chemoattractants for recruiting neural TCSCs to supernatants from damaged brain tissue. Thus, the responsiveness of infused BM-derived progenitor cells to an SDF-1 gradient could play an important role in the remodeling of damaged brain tissue similarly as demonstrated for the remodeling of vasculature in ischemic limbs 51 or myocardium after heart infarct. 30, 31, 48 Thus, appropriate modulation of both SDF-1 expression in damaged tissues as well as responsiveness of stem cells to an SDF-1 gradient may have important implications for more effective homing of TCSCs to damaged tissues and their optimal involvement in organ repair. Our data also point to a potential role of the HGF-c-Met and LIF-LIF-R axes in brain regeneration. LIF is a well-described regulator for neural stem/progenitor cells 52, 53 and our recent data demonstrate that LIF is also a potent chemoattractant for malignant neural cells (Miekus et al. (2005) . Exp. Hematol. 7 (Suppl 1): 45, abstract 30). Similarly, HGF has been reported to enhance the survival of neural cells. 54 Since TCSCs that reside in BM are mobilized into the PB following stroke, and can be potentially chemoattracted to injured brain in an SDF-1-, HGF-, and LIF-dependent manner, the question arises as to why the beneficial effects of BM-derived cells on neural tissue regeneration remains controversial. There are several potential explanations. First, the number of neural TCSCs residing in the BM may be too low (B0.01% of BMNCs) and thus insufficient to reconstitute damaged brain tissue following the extensive neural cell loss associated with stroke. The primary role of these cells may be to regenerate/repair a relatively small number of neurons that die of apoptosis in steady state. Second, circulating TCSCs may have to compete with other CXCR4 þ cells (e.g., macrophages and lymphocytes) for 'homing' into the damaged brain and thus may not effectively reach the damaged region. Third, it is possible that metalloproteinases 55 or DPPIV 56 released from granulocytes/ macrophages infiltrating ischemic/necrotic brain tissue may degrade homing signals for TCSCs. Finally, in the case of older individuals or individuals suffering from stroke, the pool of BM neural TCSCs may become depleted with time. This notion is supported by the finding that TCSCs for endothelium in older patients are circulating at much lower levels as compared to younger individuals.
Based on these observations, the major findings of the present study can be summarized as follows: (i) MNC expressing mRNA and protein for neural TCSCs are present in postnatal BM; (ii) the responsiveness of neural TCSCs to chemoattractants changes in an age-dependent fashion; (iii) neural TCSCs reside in a nonhematopoietic population of murine CXCR4 þ /Sca-1 þ /lin À / CD45 À BMMNCs; (iv) neural TCSCs are released into peripheral circulation following stroke; and (v) neural TCSCs are chemoattracted to homogenates of ischemic cortex in vitro in an SDF-1-CXCR4-, HGF-c-Met-, and LIF-LIF-R-dependent manner. To our knowledge, this is the first study to identify a specific subset of postnatal BM cells committed to neural differentiation. These observations have important conceptual implications for our understanding of BM-dependent neural regeneration and provide a rationale for further studies aimed at optimizing therapeutic neural tissue regeneration by the selective use of BM-derived TCSCs.
